U.K. agency declines to recommend Eli Lilly’s Mounjaro for type 2 diabetes
LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that
LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that
SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against
SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its
SAN DIEGO — Ozempic and Wegovy became weight loss sensations by targeting a single hormone, leading people to lose as much as 15% of their
What You Should Know: U.S. Virgin Islands (USVI) Governor Albert Bryan Jr. signed a Letter of Intent with CRISP Shared Services to participate in a
by Jasmine Pennic 06/26/2023 Leave a Comment What You Should Know: Advantus Health Partners announced a new 10-year, $2.9B strategic partnership with Medline to establish
What You Should Know: American Diabetes Association® (ADA) and Abbott announced a collaboration a new collaboration on a pilot therapeutic nutrition program to help people
by Fred Pennic 06/26/2023 Leave a Comment What You Should Know: Oaktree Capital Management has closed its Life Sciences Lending Fund with a total capital
What You Should Know: Shoni Health Ventures, a new health tech VC fund announces it’s official launch affiliated with ARC Innovation at Sheba Medical Center.